See more : Phoenix Canada Oil Company Limited (PHXCF) Income Statement Analysis – Financial Results
Complete financial analysis of SMS Pharmaceuticals Limited (SMSPHARMA.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SMS Pharmaceuticals Limited, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
You may be interested
- Dynasty Gold Corp. (DGDCF) Income Statement Analysis – Financial Results
- XRF Scientific Limited (XRF.AX) Income Statement Analysis – Financial Results
- Groclin S.A. (GCN.WA) Income Statement Analysis – Financial Results
- Cross Cat Co., Ltd. (2307.T) Income Statement Analysis – Financial Results
- Malion New Materials Co., Ltd. (300586.SZ) Income Statement Analysis – Financial Results
SMS Pharmaceuticals Limited (SMSPHARMA.NS)
About SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.09B | 5.22B | 5.15B | 5.61B | 4.07B | 4.62B | 4.61B | 6.54B | 6.03B | 5.79B | 5.18B | 2.42B | 2.14B | 2.24B | 2.20B | 2.45B | 2.10B | 1.73B | 1.29B | 1.19B |
| Cost of Revenue | 4.98B | 3.93B | 3.34B | 3.79B | 2.80B | 3.28B | 3.24B | 4.16B | 3.90B | 3.85B | 3.68B | 1.99B | 1.41B | 1.56B | 1.69B | 1.92B | 1.48B | 1.12B | 872.83M | 833.00M |
| Gross Profit | 2.11B | 1.29B | 1.81B | 1.81B | 1.27B | 1.34B | 1.36B | 2.38B | 2.13B | 1.94B | 1.50B | 429.31M | 735.15M | 686.61M | 505.45M | 529.10M | 625.41M | 612.90M | 417.49M | 353.53M |
| Gross Profit Ratio | 29.74% | 24.69% | 35.23% | 32.35% | 31.26% | 29.07% | 29.56% | 36.38% | 35.37% | 33.46% | 29.05% | 17.72% | 34.34% | 30.61% | 23.00% | 21.61% | 29.72% | 35.40% | 32.36% | 29.80% |
| Research & Development | 111.13M | 89.19M | 83.93M | 73.48M | 74.39M | 70.44M | 51.43M | 40.22M | 34.79M | 22.96M | 14.03M | 82.38M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 642.21M | 55.87M | 49.48M | 41.06M | 27.98M | 22.54M | 25.53M | 30.26M | 48.84M | 76.34M | 60.52M | 44.21M | 87.61M | 34.60M | 32.62M | 27.29M | 30.92M | 21.84M | 34.84M | 33.70M |
| Selling & Marketing | 15.86M | 38.23M | 34.21M | 50.90M | 36.99M | 22.50M | 33.35M | 84.73M | 44.57M | 92.46M | 101.23M | 33.71M | 61.06M | 65.36M | 63.41M | 57.77M | 48.10M | 90.56M | 71.45M | 62.28M |
| SG&A | 658.08M | 94.11M | 83.69M | 91.96M | 64.98M | 45.04M | 58.89M | 114.99M | 93.41M | 532.74M | 455.44M | 77.91M | 148.68M | 99.96M | 96.03M | 85.05M | 79.02M | 112.41M | 106.30M | 95.98M |
| Other Expenses | 0.00 | 48.86M | 20.59M | 25.68M | 29.66M | 20.81M | 12.85M | 9.77M | 1.33B | 1.25B | 1.06B | 747.59M | 334.91M | 231.81M | 168.98M | -24.90M | 88.42M | 64.75M | 86.69M | 71.19M |
| Operating Expenses | 769.21M | 1.07B | 989.61M | 825.62M | 693.37M | 634.00M | 626.36M | 1.59B | 1.42B | 1.25B | 1.06B | 825.50M | 483.59M | 331.77M | 265.01M | 253.20M | 167.43M | 177.15M | 192.99M | 167.18M |
| Cost & Expenses | 5.75B | 5.00B | 4.33B | 4.62B | 3.49B | 3.91B | 3.87B | 5.75B | 5.32B | 5.10B | 4.74B | 2.82B | 1.89B | 1.89B | 1.96B | 2.17B | 1.65B | 1.30B | 1.07B | 1.00B |
| Interest Income | 6.19M | 7.75M | 5.60M | 3.14M | 3.52M | 3.90M | 3.38M | 6.34M | 21.21M | 155.58M | 12.73M | 8.36M | 5.20M | 3.24M | 0.00 | 0.00 | 0.00 | 2.39M | -12.55M | -5.99M |
| Interest Expense | 234.57M | 219.15M | 181.57M | 102.54M | 111.93M | 114.20M | 147.70M | 202.90M | 155.15M | 162.55M | 137.99M | 1.97M | 241.23M | 178.72M | 135.59M | 95.90M | 68.65M | 73.69M | 53.85M | 38.84M |
| Depreciation & Amortization | 315.16M | 321.25M | 321.53M | 222.82M | 220.66M | 192.73M | 199.00M | 191.77M | 194.33M | 171.66M | 128.55M | 137.22M | 126.40M | 126.43M | 83.65M | 62.79M | 51.80M | 41.67M | 40.40M | 35.15M |
| EBITDA | 1.20B | 593.90M | 1.20B | 1.25B | 850.33M | 935.01M | 957.28M | 762.46M | 892.58M | 1.03B | 577.22M | -349.98M | 383.15M | 409.98M | 400.14M | 414.32M | 575.37M | 477.42M | 268.50M | 221.50M |
| EBITDA Ratio | 16.95% | 11.38% | 23.07% | 22.05% | 20.64% | 20.15% | 20.64% | 16.03% | 15.22% | 17.42% | 11.04% | -20.66% | 17.90% | 24.75% | 18.21% | 16.93% | 27.35% | 29.75% | 22.91% | 20.67% |
| Operating Income | 1.34B | 272.64M | 821.77M | 988.64M | 580.09M | 708.74M | 734.76M | 784.87M | 713.29M | 690.94M | 443.13M | -396.19M | 251.56M | 354.84M | 240.44M | 275.89M | 457.98M | 435.75M | 224.50M | 186.35M |
| Operating Income Ratio | 18.89% | 5.22% | 15.96% | 17.63% | 14.24% | 15.35% | 15.96% | 12.01% | 11.83% | 11.93% | 8.55% | -16.35% | 11.75% | 15.82% | 10.94% | 11.27% | 21.77% | 25.17% | 17.40% | 15.71% |
| Total Other Income/Expenses | -679.08M | -159.91M | -605.72M | -77.44M | -346.49M | -322.47M | -131.27M | -369.07M | -1.02B | -165.04M | -122.95M | 783.84M | -237.38M | -250.01M | -211.63M | -196.44M | -134.25M | -109.04M | -93.53M | -68.62M |
| Income Before Tax | 661.07M | 53.49M | 684.99M | 911.20M | 507.56M | 623.54M | 603.48M | 596.91M | 562.72M | 674.84M | 320.18M | 296.64M | 14.18M | 104.84M | 28.81M | 79.46M | 323.73M | 326.71M | 130.97M | 117.74M |
| Income Before Tax Ratio | 9.32% | 1.02% | 13.30% | 16.25% | 12.46% | 13.50% | 13.10% | 9.13% | 9.33% | 11.65% | 6.18% | 12.24% | 0.66% | 4.67% | 1.31% | 3.25% | 15.39% | 18.87% | 10.15% | 9.92% |
| Income Tax Expense | 169.07M | 14.65M | 6.18M | 301.55M | 180.67M | 209.01M | 198.94M | 115.20M | 146.33M | 322.39M | 116.34M | 43.39M | 2.80M | 20.91M | 4.85M | 16.47M | 52.12M | 117.03M | 45.90M | 33.27M |
| Net Income | 498.26M | -70.59M | 622.20M | 625.27M | 315.74M | 400.48M | 317.50M | 410.40M | 408.92M | 352.45M | 203.85M | 253.25M | 11.38M | 83.93M | 23.95M | 62.99M | 271.61M | 209.68M | 85.08M | 84.46M |
| Net Income Ratio | 7.03% | -1.35% | 12.08% | 11.15% | 7.75% | 8.67% | 6.89% | 6.28% | 6.78% | 6.08% | 3.93% | 10.45% | 0.53% | 3.74% | 1.09% | 2.57% | 12.91% | 12.11% | 6.59% | 7.12% |
| EPS | 5.89 | -0.83 | 7.35 | 7.39 | 3.73 | 4.73 | 3.75 | 3.37 | 4.83 | 4.16 | 2.31 | 2.53 | 0.11 | 0.84 | 0.24 | 0.63 | 2.72 | 2.95 | 2.08 | 2.06 |
| EPS Diluted | 5.89 | -0.83 | 7.35 | 7.39 | 3.73 | 4.73 | 3.75 | 3.37 | 4.83 | 4.16 | 2.31 | 2.53 | 0.11 | 0.84 | 0.24 | 0.63 | 2.72 | 2.95 | 2.08 | 2.06 |
| Weighted Avg Shares Out | 84.59M | 84.65M | 84.65M | 84.65M | 84.65M | 84.65M | 84.65M | 84.65M | 84.65M | 84.66M | 88.40M | 100.14M | 100.15M | 100.15M | 100.15M | 100.15M | 100.02M | 71.08M | 41.00M | 41.00M |
| Weighted Avg Shares Out (Dil) | 84.65M | 84.65M | 84.65M | 84.65M | 84.65M | 84.65M | 84.65M | 84.65M | 84.66M | 84.66M | 88.40M | 100.14M | 100.15M | 100.15M | 100.15M | 100.15M | 100.02M | 71.08M | 41.00M | 41.00M |
No news found for: SMSPHARMA.NS
Source: https://incomestatements.info
Category: Stock Reports